SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlkemy Capital. Regulatory News (ALK)

Share Price Information for Alkemy Capital. (ALK)

Share Price is delayed by 15 minutes
Get Live Data
309.00    83.00 (36.73%)
Bid:
305.00
Ask:
325.00
Spread: 20.00 (6.557%)
Market Cap: £33.92m
ALK Live PriceLast checked at - London Stock Exchange

Intraday Alkemy Capital. Share Chart

Corporate Presentation

1 Nov 2023 11:20

RNS Number : 0571S
Alkemy Capital Investments PLC
01 November 2023
 

 

 

1 November 2023

 

 

Alkemy Capital Investments Plc

 

Corporate Presentation

 

Alkemy Capital Investments plc ("Alkemy") (ALK:LSE) (JV2:FRA) is pleased to announce that its wholly-owned subsidiary Tees Valley Lithium Limited ("TVL") has posted an updated corporate presentation on its website www.teesvalleylithium.co.uk. The presentation is also available on Alkemy's website www.alkemycapital.co.uk

 

Further information

For further information, please visit the Company's website: www.alkemycapital.co.uk or www.teesvalleylithium.co.uk

-Ends-

Alkemy Capital Investments Plc

 

Tel: 0207 317 0636

info@alkemycapital.co.uk

SI Capital Limited

Tel: 0148 341 3500

VSA Capital Limited

Tel: 0203 005 5000

 

 

 

NOTES TO EDITORS

Alkemy is seeking to establish the world's leading independent and sustainable lithium hydroxide production by developing state-of-the-art lithium sulphate and lithium hydroxide facilities in Australia and the UK.

 

Alkemy, through its wholly owned UK subsidiary Tees Valley Lithium, has secured a 9.6 ha brownfields site with full planning permission at the Wilton International Chemicals Park in Teesside, a major UK Freeport, to build the UK's first and Europe's largest lithium hydroxide processing facility. Tees Valley Lithium has completed a Class 4 Feasibility Study for its proposed lithium hydroxide refinery which will process feedstock imported from various sources to produce 96,000 tonnes of premium, low-carbon lithium hydroxide annually, representing around 15% of Europe's projected demand.

 

Alkemy, through its wholly owned Australian subsidiary Port Hedland Lithium, has secured a 43.7 ha site near Port Hedland, Western Australia to build a world-class sustainable lithium

 

 

sulphate refinery that will provide reliable feedstock for Tees Valley Lithium's refinery. Port Hedland Lithium has completed a Class 4 Feasibility Study for its proposed lithium sulphate refinery, each train of which will process spodumene concentrate to produce 40,000 tonnes of lithium sulphate annually.

 

 

Forward Looking Statements

This news release contains forward?looking information. The statements are based on reasonable assumptions and expectations of management and Alkemy provides no assurance that actual events will meet management's expectations. In certain cases, forward?looking information may be identified by such terms as "anticipates", "believes", "could", "estimates", "expects", "may", "shall", "will", or "would". Although Alkemy believes the expectations expressed in such forward?looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those projected. Mining exploration and development is an inherently risky business. In addition, factors that could cause actual events to differ materially from the forward-looking information stated herein include any factors which affect decisions to pursue mineral exploration on the relevant property and the ultimate exercise of option rights, which may include changes in market conditions, changes in metal prices, general economic and political conditions, environmental risks, and community and non-governmental actions. Such factors will also affect whether Alkemy will ultimately receive the benefits anticipated pursuant to relevant agreements. This list is not exhaustive of the factors that may affect any of the forward?looking statements. These and other factors should be considered carefully and readers should not place undue reliance on forward-looking information.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFLLLLLLIIV
Date   Source Headline
20th Jan 20144:24 pmRNSTR-1: Notification of Major Interest in Shares
20th Jan 20147:00 amRNSTrading Update and Notice of Results
16th Jan 20147:00 amRNSHolding(s) in Company
16th Jan 20147:00 amRNSHolding(s) in Company
9th Jan 201410:06 amRNSTR-1: Notification of Major Interest in Shares
24th Dec 20131:29 pmRNSTotal Voting Rights
9th Dec 20134:38 pmRNSHolding(s) in Company
1st Nov 20137:00 amRNSChange of Nominated Adviser
24th Oct 20131:51 pmRNSDirector/PDMR Shareholding
3rd Oct 20132:15 pmRNSAward of Performance Shares
11th Sep 20137:00 amRNSInterim Results
8th Aug 20137:50 amRNSHolding(s) in Company
8th Aug 20137:50 amRNSHolding(s) in Company
5th Aug 201311:26 amRNSAcquisition of Licence
24th Jul 201310:55 amRNSAcquisition of Licence and Third Party Royalty
9th Jul 20137:00 amRNSNotice of Results and Trading Update
28th May 20133:13 pmRNSHolding(s) in Company
28th May 20132:15 pmRNSAward of Performance Shares
28th May 201310:13 amRNSHolding(s) in Company
24th May 20139:29 amRNSCompletion of Acquisition and Fundraising
24th May 20139:28 amRNSTotal Voting Rights
23rd May 201311:48 amRNSHolding(s) in Company
22nd May 20137:00 amRNSAcquisition and Fundraising
16th May 201310:18 amRNSGrant of SAYE Share Options
1st May 20132:58 pmRNSAppointment of Joint Broker
1st May 20132:36 pmRNSResult of AGM
1st May 20137:00 amRNSAGM Statement and Trading Update
22nd Apr 20137:00 amRNSPublication of Report & Accounts
18th Apr 201311:48 amRNSHolding(s) in Company
12th Apr 201312:54 pmRNSHolding(s) in Company
13th Mar 20137:00 amRNSPreliminary results
6th Feb 201310:09 amRNSHolding(s) in Company
18th Jan 20137:00 amRNSNotice of Results and Trading Update
16th Jan 201310:06 amRNSAdditional Listing
6th Nov 20127:00 amRNSDirector/PDMR Shareholding
26th Oct 201212:28 pmRNSHolding(s) in Company
26th Oct 201211:24 amRNSTotal Voting Rights
25th Oct 20127:00 amRNSDirector/PDMR Shareholding
19th Oct 20127:00 amRNSAdditional Listing
11th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 20129:02 amRNSDirector/PDMR Shareholding
1st Oct 20127:00 amRNSDirectorate Change
21st Sep 20127:00 amRNSGrant of Share Options
12th Sep 20127:00 amRNSInterim Results
3rd Sep 20128:53 amRNS£1.6m Biogas Contract
29th May 201212:28 pmRNSResult of AGM
29th May 20127:00 amRNSTrading Statement
14th May 20129:59 amRNSHolding(s) in Company
10th May 20129:20 amRNSTotal Voting Rights
8th May 201210:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.